-
Village People singer Victor Willis dies at 74
-
Genesio replaces Beye as Marseille boss
-
Thousands rush to get tickets for Bayeux Tapestry's UK show
-
Catholic society defies Vatican again by ordaining new bishops
-
Chinese firm sells hyper-real, 'always loyal' humanoid robots
-
Breakaway Catholic society defies Vatican again by ordaining bishops
-
World's oceans break June heat record: EU monitor
-
Venezuelans search, suffer one week after deadly quakes
-
China imposes 'national security' rules on overseas investments
-
Asian stocks mostly up as traders eye crucial US jobs data
-
'Nothing left except death': Myanmar families grieve huge war toll
-
Ronaldo and Modric struggle to defy Father Time at World Cup
-
England face DR Congo hurdle, USA prepare for World Cup moment in spotlight
-
The secret lives of Ukraine's deep-strike drone team
-
Myanmar mourns as post-coup conflict death toll hits 100,000
-
NATO project tests perennial grass to clean Ukraine's war-hit soil
-
Vietnam unveils 'baby bonus' after scrapping two-child policy
-
Duffy returns for New Zealand against West Indies
-
Majestic Olise raises France to another level at World Cup
-
Mbappe dazzles as France march on at World Cup; Norway, Mexico advance
-
Mexico see off Ecuador to break 40-year World Cup curse
-
US govt lifts restrictions on powerful AI models, Anthropic says
-
'My dream is broken': Japan visa rules push out foreign residents
-
Trump earned over $1 bn from crypto ventures in 2025
-
Indian sailors fear returning to Gulf after Middle East war
-
The Afghan women farmers keeping their village alive
-
Fear and anger brew inside Meta amid AI frenzy
-
Asian stocks fluctuate as traders eye crucial US jobs data
-
After 250 years, the 'American dream' is tarnished but alive
-
Madison Square Garden: from Nazis to Knicks, and now... Taylor's wedding?
-
'I'm going to stay calm': 48 hours under the rubble in Venezuela
-
'Love it': Wimbledon's military stewards tradition turns 80
-
Breakaway Catholic sect defies Vatican again by ordaining bishops
-
Venezuela quake survivors cherish kindness of strangers
-
Mexico v Ecuador World Cup game delayed by one hour: FIFA
-
US deports first migrant to Pacific nation Palau
-
Talks in Qatar after US-Iran deal: What we know
-
Potter admits Sweden couldn't live with France in World Cup defeat
-
MSC Industrial Supply Co. Reports Fiscal 2026 Third Quarter Results
-
BioLargo Engineering Unit Awarded $1.4 Million in U.S. Air Force Environmental Contract Renewals
-
Lennys Grill & Subs Launches Veteran Franchise Program to Support Military Veterans in Business Ownership
-
Who Does Gender Affirming Surgery Without a Weight Limit?
-
PersonalHour Expands Manufacturing and Fulfillment Operations Across the United States
-
State Licensed Cannabis Companies Move To Intervene In MMJ's D.C. Circuit Litigation To Stop Rescheduling
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 01
-
Tuchel refuses to dampen England World Cup expectations
-
US coach dismisses European jinx ahead of Bosnia clash
-
Mbappe hails unity as France rally around Deschamps at World Cup
-
World Bank to phase out lending to China by 2031
-
Mbappe fires France into World Cup last 16, Norway advance
Cellev8 Nutrition Files Two Patents at US Trademark and Patent Office
Cellev8 Nutrition Inc (OTC PINK:CELV), a pioneer in Superoxide Dismutase (SOD) based supplements, has announced the filing of two patents to protect its groundbreaking delivery systems. These patents are set to revolutionize the company's product lines and enhance the proprietary transport of SOD and other powerful ingredients throughout the body to enhance wellness, and promote health and anti aging from cellular levels.
Advancing Supplement Technology
The patent-pending formulations represent a significant leap forward in supplement technology worldwide. Cellev8's delivery mechanisms have proven effect with thousands of people by focusing on reducing oxidative stress and providing superior cellular protection in the body. Cellev8 revolutionizes supplement effectiveness by employing advanced delivery mechanisms to enhance SOD absorption and combining it with powerful, targeted ingredients. This innovative approach maximizes the potency and precision of their products, delivering optimal benefits to specific areas of the body. These innovations are expected to further solidify the company's position as a leader in the wellness industry.
Key Highlights of the Patent Filings:
• Enhanced Ingredient Delivery: The new systems are designed to improve the absorption and utilization of key ingredients, including the company's flagship SOD formulations.
• Proprietary Transport Mechanisms: Cellev8's unique approach ensures that active compounds reach their intended targets more efficiently within the body.
• Broad Application: The patents cover delivery systems applicable across Cellev8's entire product range, including their popular inflammation and recovery gummies.
Impact on Product Lines
Michael Ferraro, CEO of Cellev8 Nutrition, commented on the patent filings: "These patents represent a culmination of our research and development efforts. They will not only protect our intellectual property but also pave the way for more effective and innovative wellness solutions for our customers. Imagine supplements that not only deliver powerful key ingredients more efficiently but also provides a precisely tailored blend of nutrients and critical anti-oxidants to support your body's unique needs. That's the Cellev8 difference! With our innovative approach, we're not just creating supplements - we're crafting personalized solutions for optimal health and vitality.."
The new delivery systems are expected to enhance the performance of Cellev8's existing products, including:
• Inflammation & Recovery Gummies
• Focus & Memory Gummies
• GLP1 Support Gummies
Future Prospects
With these patent filings, Cellev8 Nutrition is poised to expand its market presence with a lineup of additional products and potentially collaborate with larger nutraceutical and pharmaceutical companies interested in leveraging the benefits of their enhanced delivery process.
The company continues to focus on developing cutting-edge wellness products that promote health and vitality, serving thousands of customers, including over 40 professional and collegiate athletic teams, clients of FDA certified Zyppah products and patients/clients of publicly traded FDA approved sleep apnea company Vivos Therapeutics Inc.
For more information about Cellev8 Nutrition Inc and its innovative product line, visit www.cellev8.com
W.Nelson--AT